

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.31%
-8.88%
+2.71%
+2.81%
+9.75%
COHR
Coherent Corp.
$129.34
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Chart
$107.97 (+19.79%)
$102.79 (+25.83%)
$81.63 (+58.45%)
$109.45 (+18.17%)
COHR has Medium Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Investors losing confidence

COHR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
COHR Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
COHR Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is COHR current stock price?
What are COHR stock strengths?
What risks are associated with COHR stock?
When is COHR next earnings report?
What is COHR market cap and volume?
What is COHR's current Stock IQ?
Should I buy COHR stock right now?
Is COHR a Strong Buy right now?
What does a 'Strong Buy' rating mean for COHR?
What does a 'Strong Sell' rating mean for COHR?
What factors influence COHR's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.31%
-8.88%
+2.71%
+2.81%
+9.75%
COHR
Coherent Corp.
Current Price
$129.34
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Chart
$107.97 (+19.79%)
$102.79 (+25.83%)
$81.63 (+58.45%)
$109.45 (+18.17%)
COHR Analysts Opinion
COHR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
COHR Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
COHR Street view is extremely bullish and have positive views on the near-term outlook
COHR has Medium Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Investors losing confidence

Average key support and resistance price levels.
COHR Latest Analysis
The Analyst Verdict: Coherent In The Eyes Of 10 Experts. Coherent (NYSE:) underwent analysis by 10 analysts in the last quarter revealing a spectrum of viewpoints from ish to bearish.The table below provides a concise overview of recent ratings by analysts offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.3340000100000003120002100Insights from analysts'. 12-month price targets are revealed present
Fri Oct 10, 2025
Wood Manufacturing Market Size to worth USD 626.77 Billion by 2032 Growing at 2.3% CAGR Coherent Market Insights. is estimated to be valued at USD 534.54 Bn in 2025 and is expected to reach USD 626.77 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 2.3% from 2025 to 2032.Current market trends reveal a strong shift toward sustainable renewable and eco-friendly building materials fueled by increasing environmental consciousness and strict regulations on carbon emissions. Advancement
Fri Oct 10, 2025
Sleep Tech Devices Market to Hit $68.78 Billion by 2032 at a CAGR of 16.7% says Coherent Market Insights. is estimated to be valued at USD 23.32 Bn in 2025 and is expected to reach USD 68.78 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 16.7% from 2025 to 2032. Technological innovations such as wearable sleep trackers and mobile apps are rapidly gaining popularity among consumers. Increasing awareness of sleep disorders and their effects on overall health is encouraging individu
Thu Oct 9, 2025
Veterinary Ultrasound Market to Surpass $907.9 Million by 2032 at 7.6% CAGR: Coherent Market Insights. is estimated to be valued at USD 543.3 Million in 2025 and is expected to reach USD 907.9 Million by 2032 exhibiting a compound annual growth rate (CAGR) of 7.6% from 2025 to 2032. The veterinary ultrasound market is witnessing steady growth fueled by the growing rate of pet adoption and increasing awareness of animal health and wellness. Additionally the rising incidence of zoonotic diseases
Thu Oct 9, 2025
Dermal Fillers Market Set to Surpass USD 10.97 Billion in 2032 says Coherent Market Insights. is estimated to be valued at USD 5.12 Bn in 2025 and is expected to reach USD 10.97 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032. This notable growth is fueled by the rising consumer preference for minimally invasive cosmetic treatments and the increasing global awareness of aesthetic enhancement options. Additionally technological advancements and the introduct
Wed Oct 8, 2025
Veterinary Dermatology Drugs Market Set to Exceed USD 5.1 Billion in 2032 says Coherent Market Insights. is estimated to be valued at USD 3.04 Bn in 2025 and is expected to reach USD 5.1 Bn in 2032 exhibiting a compound annual growth rate (CAGR) of7.67% from 2025 to 2032. The growth of the veterinary dermatology drugs market is driven by the rising incidence of skin disorders among animals the increasing rate of pet adoption and growing awareness regarding animal health and wellness. Additional
Tue Oct 7, 2025
Real Estate Software Market to Hit $34.1 Billion by 2032 at a CAGR of 14.0% says Coherent Market Insights. is estimated to be valued at USD 13.65 Bn in 2025 and is expected to reach USD 34.1 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 14.0% from 2025 to 2032. The global real estate software market is projected to experience strong growth over the forecast period. Increasing digital transformation and the widespread adoption of cloud-based technologies are driving real estate c
Tue Oct 7, 2025
How NLP And AI Are Redefining Search And Why Investors Should Pay Attention.
Mon Oct 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
COHR Stock trends
COHR Stock performance
COHR Stock analysis
COHR investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.